Antonella Mancuso named chief manufacturing officer of Patheon; Allergan invests $350 million in plant in Ireland;

> Antonella Mancuso has been promoted to global commercial operations president and chief manufacturing officer for drug development and manufacturing services company Patheon ($PTI.TO). Release

> Allergan ($AGN) will invest about $350 million for a Botox manufacturing facility in Westport in County Mayo, Ireland, in the next four years. Eventually, it expects to have 1,050 working at the facility in the town of 6,000. Story

> Boehringer Ingelheim introduced what it calls a "Lean-to-Clinic" service, which it claims will deliver drug substances for toxicological and clinical studies in 13 months and drug products for clinical studies after 16 months. Release

> The FDA has updated its Q&A page to help manufacturers of topical antiseptics prevent contamination. Story

Suggested Articles

Transporting pharmaceutical products at <-60C for more than 96 hours has seemed an insurmountable challenge. TOWER’s solution has solved the problem.

Roche will spend $500 million for a new global manufacturing logistics hub in Canada that will eventually employ 500 workers in Ontario.

Fledgling Indiana CDMO Incog BioPharma Services is shelling out $60 million to get its first manufacturing facility off the ground.